Fate Therapeutics FATE Earnings Call Transcripts

NASDAQ FATE
$1.61 -0.16 (-9.32%)
At close: Nov 11, 2026 · 4:00 PM EST
8 earnings calls on file for Fate Therapeutics, from Q4 2019 to Q3 2021. Each transcript opens in a new tab.
Latest earnings call

Fate Therapeutics Q3 2021 Earnings Call

Nov 4, 2021 8,806 words · 38 min read
  • Scott WolchkoPresident and Chief Executive Officer
  • Edward DulacChief Financial Officer
  • Yu-Waye (Wayne) Chu.Senior Vice President, Clinical Development
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Fate Therapeutics Earnings Call Transcripts

Calls8
LatestNov 4, 2021
SinceQ4 2019

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 8 Fate Therapeutics transcripts Register to get access to Fate Therapeutics’s earnings call transcripts.